ATE480561T1 - Verfahren zur festphasen-peptidsynthese - Google Patents

Verfahren zur festphasen-peptidsynthese

Info

Publication number
ATE480561T1
ATE480561T1 AT05796944T AT05796944T ATE480561T1 AT E480561 T1 ATE480561 T1 AT E480561T1 AT 05796944 T AT05796944 T AT 05796944T AT 05796944 T AT05796944 T AT 05796944T AT E480561 T1 ATE480561 T1 AT E480561T1
Authority
AT
Austria
Prior art keywords
solid phase
peptide synthesis
phase peptide
devised
synthesizing
Prior art date
Application number
AT05796944T
Other languages
English (en)
Inventor
Anne-Sophie Droz
Jasmine Schnidrig
Nicole Studer
Stephane Varray
Corinne Wenger
Oleg Werbitzky
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Application granted granted Critical
Publication of ATE480561T1 publication Critical patent/ATE480561T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT05796944T 2004-10-19 2005-10-19 Verfahren zur festphasen-peptidsynthese ATE480561T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04024812 2004-10-19
PCT/EP2005/011226 WO2006045503A1 (en) 2004-10-19 2005-10-19 Method for solid phase peptide synthesis

Publications (1)

Publication Number Publication Date
ATE480561T1 true ATE480561T1 (de) 2010-09-15

Family

ID=35427609

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05796944T ATE480561T1 (de) 2004-10-19 2005-10-19 Verfahren zur festphasen-peptidsynthese

Country Status (11)

Country Link
US (2) USRE46830E1 (de)
EP (1) EP1737889B1 (de)
JP (1) JP4903709B2 (de)
CN (2) CN101094867B (de)
AT (1) ATE480561T1 (de)
DE (1) DE602005023429D1 (de)
DK (1) DK1737889T3 (de)
ES (1) ES2352204T3 (de)
IL (1) IL182698A (de)
PT (1) PT1737889E (de)
WO (1) WO2006045503A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070093423A1 (en) * 2005-09-14 2007-04-26 Avi Tovi Process for production of Bivalirudin
US20080287650A1 (en) * 2007-03-01 2008-11-20 Avi Tovi High purity peptides
US7598343B1 (en) 2008-07-27 2009-10-06 The Medicines Company Pharmaceutical formulations of bivalirudin and processes of making the same
US7582727B1 (en) 2008-07-27 2009-09-01 The Medicinces Company Pharmaceutical formulations of bivalirudin and processes of making the same
US8252896B2 (en) * 2008-09-03 2012-08-28 ScnioPharm Taiwan, Ltd. Process for making bivalirudin
MX2011006950A (es) * 2008-12-29 2011-07-28 Lonza Braine S A Proceso para la produccion de bivalirudina.
CN101475631B (zh) * 2009-01-08 2011-08-17 苏州中科天马肽工程中心有限公司 比伐卢定的液相合成方法
US20110160431A1 (en) 2009-04-06 2011-06-30 Novetide, Ltd. Production of peptides containing poly-gly sequences using fmoc chemistry
CN101555274B (zh) * 2009-05-15 2013-08-21 海南双成药业股份有限公司 一种多肽固相合成比法卢定粗品的制备方法
WO2013042129A1 (en) 2011-09-23 2013-03-28 Natco Pharma Limited Improved process for preparation of bivalirudin
US9388212B2 (en) 2013-02-21 2016-07-12 Chemical & Biopharmaceutical Laboratories Of Patras S.A. Solid phase peptide synthesis via side chain attachment
JP6382488B2 (ja) * 2013-02-21 2018-08-29 ケミカル アンド バイオファーマシューティカル ラボラトリーズ オブ パトラ エス．エー． 側鎖結合を介する固相ペプチド合成
GB201310921D0 (en) 2013-06-19 2013-07-31 Chemical & Biopharmaceutical Lab Of Patras S A Peptide-resin conjugate and use thereof
EP3199540A4 (de) * 2014-09-26 2018-05-09 Kaneka Corporation Verfahren zur herstellung von hydrophoben peptiden
CN108383905A (zh) * 2016-12-30 2018-08-10 江苏金斯瑞生物科技有限公司 一种比伐卢定的制备方法
CN112111001B (zh) * 2019-06-19 2021-10-29 翰宇药业（武汉）有限公司 胸腺肽Tα-1的合成方法
JP2020138975A (ja) * 2020-05-18 2020-09-03 ケミカル アンド バイオファーマシューティカル ラボラトリーズ オブ パトラ エス．エー． 側鎖結合を介する固相ペプチド合成

Family Cites Families (154)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093610A (en) 1977-01-31 1978-06-06 American Home Products Corporation Process for producing triglycyl-lysine vasopressin and intermediates therefor
US4108846A (en) 1977-02-01 1978-08-22 Hoffmann-La Roche Inc. Solid phase synthesis with base N alpha-protecting group cleavage
US4169141A (en) 1978-01-30 1979-09-25 Shering Corporation 1-Peptidyl derivatives of di-O-aminoglycosyl-1,3-diaminocyclitol antibacterial agents
US6005071A (en) 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5789540A (en) 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US6239101B1 (en) 1989-07-05 2001-05-29 Oklahoma Medical Research Foundation Thrombin binding polypeptides
US5240913A (en) 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
US5196404B1 (en) 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
EP0502962B1 (de) 1989-12-01 1996-03-13 BASF Aktiengesellschaft Hirudin-Muteine und deren Polyalkylenglykolkonjugate
US5624822A (en) 1989-12-22 1997-04-29 Basf Aktiengesellschaft Hirudin fusion proteins and preparation of hirudin
AU641215B2 (en) 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4016596A1 (de) 1990-05-23 1991-11-28 Hoechst Ag Ein neues kupplungsreagenz fuer die peptidsynthese
US6060451A (en) 1990-06-15 2000-05-09 The National Research Council Of Canada Thrombin inhibitors based on the amino acid sequence of hirudin
US5574012A (en) 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
ES2129749T3 (es) 1990-11-08 1999-06-16 Japan Energy Corp Vector de secrecion, microorganismos transformados que contienen el indicado vector y produccion de un producto a partir de dicho microorganismo.
US5242810A (en) 1990-12-07 1993-09-07 Biogen, Inc. Bifunctional inhibitors of thrombin and platelet activation
CA2101331A1 (en) 1991-02-04 1992-08-05 Johannes W.F.M. Van Nispen Factor iia inhibitors
DE4103649A1 (de) 1991-02-07 1992-08-13 Basf Ag Neue antikoagulatorisch wirksame peptide
EP0570493B1 (de) * 1991-02-08 2000-01-05 Diatide, Inc. Technetium-99m markierte Polypeptide zur Bildformung
US5767235A (en) 1991-03-05 1998-06-16 Nippon Mining Company Limited Anticoagulant hirudin variants and methods for their production
US6514730B1 (en) 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
GB9112825D0 (en) 1991-06-14 1991-07-31 Ici Plc Process for making peptides
US5837808A (en) 1991-08-20 1998-11-17 Baxter International Inc. Analogs of hirudin
GB9118669D0 (en) 1991-08-30 1991-10-16 Univ Southampton Preparation of peptides by a soliphase synthesis and intermediates therefor
DE4209110A1 (de) 1991-11-26 1993-05-27 Basf Ag Neue thrombininhibitorische proteine aus landblutegeln
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
US5371184A (en) 1992-02-05 1994-12-06 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5492895A (en) 1992-02-14 1996-02-20 Corvas International, Inc. Inhibitors of thrombosis
FR2687681B1 (fr) 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
GB9209032D0 (en) 1992-04-25 1992-06-10 Ciba Geigy Ag New peptide derivatives
US5968476A (en) 1992-05-21 1999-10-19 Diatide, Inc. Technetium-99m labeled peptides for thrombus imaging
CN1088836A (zh) * 1992-12-30 1994-07-06 中国科学院生物物理研究所 重组水蛭素及其复合物用于制备预防和治疗血栓病药物
US5656600A (en) 1993-03-25 1997-08-12 Corvas International, Inc. α-ketoamide derivatives as inhibitors of thrombosis
DE4310632A1 (de) 1993-04-01 1994-10-06 Merck Patent Gmbh Lineare Adhäsionsinhibitoren
IT1265023B1 (it) 1993-04-16 1996-10-28 Dev Biotechnological Processes Inibitori della trombina, loro preparazione ed uso per applicazioni terapeutiche, profilattiche e diagnostiche
US5443827A (en) 1993-05-03 1995-08-22 President And Fellows Of Harvard College Fibrin-targeted inhibitors of thrombin
EP0702696B1 (de) 1993-06-11 2003-07-30 Merrell Pharmaceuticals Inc. Trifunktionelle antithrombin-und antiplättchenpeptide
US5457177A (en) 1993-06-16 1995-10-10 Merck & Co., Inc. Thrombin receptor radioligands
DE4323754C1 (de) 1993-07-15 1994-12-01 Gruenenthal Gmbh Bifunktionelle Urokinasevarianten mit verbesserten fibrinolytischen Eigenschaften und thrombinhemmender Wirkung
DE69408145T2 (de) 1993-07-19 1998-09-03 Resolution Pharm Inc Hydrazine mit einer n3s konfiguration als radionukleide chelatoren
US5972648A (en) 1993-09-28 1999-10-26 Japan Energy Corporation Hirudin analogs, methods of manufacture thereof and anticoagulant compositions having these as active ingredients
US5449761A (en) 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
FR2710917B1 (fr) 1993-10-07 1995-11-24 Adir Nouveaux dérivés de peptides thérapeutiquement actifs dans la cascade de coagulation sanguine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES2153433T3 (es) 1993-10-25 2001-03-01 Ca Nat Research Council Inhibidores de trombina bivalentes.
US7060484B1 (en) 1993-11-12 2006-06-13 Gilead Sciences, Inc. Polypeptides and coagulation therapy
US6156540A (en) 1993-12-22 2000-12-05 Human Genome Sciences, Inc. Thrombin inhibitor
DE4404168A1 (de) 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5662885A (en) 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5759542A (en) 1994-08-05 1998-06-02 New England Deaconess Hospital Corporation Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases
KR0141651B1 (ko) 1994-09-07 1998-06-15 강재헌 금속이온 친화성 크로마토그라피를 이용한 히루딘의 정제방법
DE4440892A1 (de) 1994-11-17 1996-05-23 Gruenenthal Gmbh Proteine mit fibrinolytischen und gerinnungshemmenden Eigenschaften
DE4442665A1 (de) 1994-11-30 1996-06-05 Gruenenthal Gmbh Chimäre Proteine mit fibrinolytischen und thrombinhemmenden Eigenschaften
US5747453A (en) 1995-06-06 1998-05-05 Alza Corporation Method for increasing the electrotransport flux of polypeptides
US5817758A (en) 1995-06-07 1998-10-06 Terrapin Technologies, Inc. P-nitrobenzyl side-chain protection for solid-phase synthesis
US5767078A (en) 1995-06-07 1998-06-16 Johnson; Dana L. Agonist peptide dimers
JP4067117B2 (ja) 1995-06-09 2008-03-26 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 選択性スロンビン抑制剤としてのブラジキニン同族体
IL119466A (en) 1995-11-03 2001-08-26 Akzo Nobel Nv Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
US5910481A (en) 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US6333189B1 (en) 1996-06-06 2001-12-25 Alza Corporation Method of making an electrotransport device
US7176282B1 (en) 1996-09-09 2007-02-13 Zealand Pharma A/S Solid-phase peptide synthesis and agent for use in such synthesis
CZ295838B6 (cs) 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
US6265204B1 (en) 1997-01-17 2001-07-24 Genencor International, Inc. DNA sequences, vectors, and fusion polypeptides for secretion of polypeptides in filamentous fungi
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US6077825A (en) 1997-03-13 2000-06-20 Auburn University Antithrombin protein and DNA sequences from black fly
GB9708918D0 (en) 1997-05-01 1997-06-25 Ppl Therapeutics Scotland Ltd Methods
WO1999046283A1 (en) 1998-03-09 1999-09-16 Zealand Pharmaceuticals A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US6281331B1 (en) 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6451992B1 (en) 1998-08-20 2002-09-17 Auburn University Antithrobin nucleotides and proteins from horn fly
BR0009674A (pt) 1999-04-09 2002-01-15 Basf Ag Composto, droga, e, uso de composto
ES2154590B1 (es) 1999-05-20 2001-11-01 Lipotec Sa Procedimiento de sintesis de peptidos en fase solida
US6544750B1 (en) 1999-08-17 2003-04-08 Thromgen, Inc. Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1
EP1138694A1 (de) 2000-03-30 2001-10-04 University Of Manitoba Hirulog-ähnliches Peptid
US6506761B1 (en) 2000-04-14 2003-01-14 Corvas International, Inc. Substituted hydrazinyl heteroaromatic inhibitors of thrombin
JP2002112782A (ja) 2000-10-04 2002-04-16 Ajinomoto Co Inc 抗血栓活性を有する蛋白質及びその製造法
DE10102878A1 (de) 2001-01-23 2002-08-01 Haemosys Gmbh Oligo- oder Polyalkylengekoppelte Thrombininhibitoren
US7427260B2 (en) 2001-03-30 2008-09-23 Mayo Foundation For Medical Education And Research Efficient methods for solid phase synthesis using trityl chloride resins
AU2002320067A1 (en) 2001-06-08 2002-12-23 Emory University Antithrombotic thrombin variants
US6703364B2 (en) 2001-07-23 2004-03-09 Cleveland State University Thrombin generation inhibitors
EP1425296B1 (de) 2001-09-10 2011-04-13 Novel Science International GmbH Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
GB0123262D0 (en) 2001-09-27 2001-11-21 Adprotech Ltd Polymeric compounds
KR100718431B1 (ko) 2001-11-27 2007-05-14 주식회사 유앤비케미칼 트리틸기가 도입된 폴리스티렌 수지의 제조 방법
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
AU2003236080B8 (en) 2002-04-11 2009-07-02 Daiichi Sankyo Company, Limited A method for producing a modified peptide
EP1504022B1 (de) 2002-05-03 2006-10-11 Avecia Limited Verfahren zur herstellung von peptidamiden durch seitenkettenanknüpfung an einer festphase
US6875893B2 (en) 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
AU2002329070A1 (en) 2002-08-26 2004-03-11 A & Pep Inc Method for synthesizing peptides
DK1578812T3 (da) 2002-12-20 2006-08-14 Hoffmann La Roche Fremgangsmåde til genindvinding af fastfase-bundet CTC-resin
DE10301255A1 (de) 2003-01-15 2004-07-29 Cpi Creative Pharma International Gmbh Organische Verbindungen mit biologischer Wirkung als Thrombinhemmer und ihre Verwendung
US7456152B2 (en) 2003-02-27 2008-11-25 National Research Council Of Canada Peptide inhibitors of thrombin as potent anticoagulants
US7074765B2 (en) 2003-05-01 2006-07-11 The Regents Of The University Of Michigan Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
US7393920B2 (en) 2003-06-23 2008-07-01 Cem Corporation Microwave-assisted peptide synthesis
WO2004113386A2 (en) 2003-06-26 2004-12-29 Merck Patent Gmbh Modified hirudin proteins and t-cell epitopes in hirudin
DE602004031736D1 (de) 2003-07-04 2011-04-21 Lonza Ag Verbessertes verfahren für festphasensynthese
US7135534B2 (en) 2003-07-24 2006-11-14 Rajiv Gandhi Centre For Biotechnology Polymer support for solid phase peptide synthesis and process for preparation thereof
GB0318205D0 (en) 2003-08-02 2003-09-03 Albachem Ltd Synthetic method
EP1701969B1 (de) 2003-12-31 2007-10-24 F.Hoffmann-La Roche Ag Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
US20080025966A1 (en) 2004-01-30 2008-01-31 Currie Mark G Methods And Compositions For The Treatment Of Gastrointestinal disorders
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
EP1600455A1 (de) 2004-05-28 2005-11-30 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Herstellung Festphasen gebundener Peptide oder PNAs
US8063018B2 (en) 2004-06-23 2011-11-22 National Research Council Of Canada Bivalent thrombin binding molecules comprising linkers
CA2572754A1 (en) 2004-07-12 2006-02-16 Applera Corporation Mass tags for quantitative analyses
WO2006102069A2 (en) 2005-03-17 2006-09-28 Microbia, Inc. Methods and compositions for the treatment of hypertension and gastrointestinal disorders
JP2008534628A (ja) 2005-05-03 2008-08-28 ノベタイド，リミティド ペプチド誘導体の製造のための方法
US7879792B2 (en) 2005-06-02 2011-02-01 The Regents Of The University Of Michigan Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4
US20070093423A1 (en) 2005-09-14 2007-04-26 Avi Tovi Process for production of Bivalirudin
KR101323849B1 (ko) 2005-12-09 2013-11-07 브라코 스위스 에스.에이. 표적화 벡터-포스포리피드 컨쥬게이트
US8314208B2 (en) 2006-02-10 2012-11-20 Cem Corporation Microwave enhanced N-fmoc deprotection in peptide synthesis
CN101033249B (zh) 2006-03-10 2011-05-11 周逸明 固相多肽合成比筏芦定的制备方法
US20080096819A1 (en) 2006-05-02 2008-04-24 Allozyne, Inc. Amino acid substituted molecules
AU2007248855A1 (en) 2006-05-03 2007-11-15 Mallinckrodt Inc. Composition and method for the release of protected peptides from a resin
WO2008009672A1 (en) 2006-07-21 2008-01-24 Solvay (Societe Anonyme) Process for the manufacture of peptides
WO2008057683A2 (en) 2006-10-03 2008-05-15 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
WO2008058016A2 (en) 2006-11-02 2008-05-15 University Of Virginia Patent Foundation Ethoid-containing compounds, methods for preparing ethoid-containing compounds, and methods for use
IE20060841A1 (en) 2006-11-21 2008-05-28 Ipsen Mfg Ireland Ltd Boc and fmoc solid phase peptide synthesis
PT2101760E (pt) 2006-12-08 2013-05-07 Millennium Pharm Inc Formulações de dose unitária e métodos de tratamento da trombose com um inibidor oral do fator xa
JP5345069B2 (ja) 2006-12-15 2013-11-20 インスティテュート オブ ラジエーション メディシン，アカデミー オブ ミリタリー メディカル サイエンシズ，ピーエルエー 低出血性抗凝固性融合タンパク質の調製および使用
CN101245110B (zh) 2007-02-16 2010-09-15 鲁南制药集团股份有限公司 重组中性粒细胞抑制因子和水蛭原嵌合蛋白及其药物组合物
US20080287650A1 (en) 2007-03-01 2008-11-20 Avi Tovi High purity peptides
GB0711779D0 (en) 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
WO2009014177A1 (ja) 2007-07-25 2009-01-29 Ajinomoto Co., Inc. ジベンゾフルベン誘導体の淘汰方法
CN101372512B (zh) 2007-08-23 2011-03-23 中国人民解放军军事医学科学院生物工程研究所 一类抗凝血多肽及其用途
US20090062511A1 (en) 2007-09-05 2009-03-05 Raghavendracharyulu Venkata Palle Process for the preparation of bivalirudin and its pharmaceutical compositions
EP2280993A1 (de) 2008-05-15 2011-02-09 Novo Nordisk A/S Reinigung von durch festphasensynthese hergestellten peptiden
US7582727B1 (en) 2008-07-27 2009-09-01 The Medicinces Company Pharmaceutical formulations of bivalirudin and processes of making the same
US7598343B1 (en) 2008-07-27 2009-10-06 The Medicines Company Pharmaceutical formulations of bivalirudin and processes of making the same
JP5445456B2 (ja) 2008-08-06 2014-03-19 味の素株式会社 ジベンゾフルベンの除去方法
US20110288235A1 (en) 2008-09-03 2011-11-24 Scinopharm Taiwan Ltd. Process for the Preparation of Pramlintide
US8252896B2 (en) 2008-09-03 2012-08-28 ScnioPharm Taiwan, Ltd. Process for making bivalirudin
WO2010054503A1 (zh) 2008-11-17 2010-05-20 中国人民解放军军事医学科学院生物工程研究所 抗凝血多肽及其应用
MX2011006950A (es) 2008-12-29 2011-07-28 Lonza Braine S A Proceso para la produccion de bivalirudina.
CN101475631B (zh) 2009-01-08 2011-08-17 苏州中科天马肽工程中心有限公司 比伐卢定的液相合成方法
US20110160431A1 (en) 2009-04-06 2011-06-30 Novetide, Ltd. Production of peptides containing poly-gly sequences using fmoc chemistry
GB0907698D0 (en) 2009-05-05 2009-06-10 Univ Singapore Method of modifying serine protease inhibitors
CN101555274B (zh) 2009-05-15 2013-08-21 海南双成药业股份有限公司 一种多肽固相合成比法卢定粗品的制备方法
US7803762B1 (en) 2009-08-20 2010-09-28 The Medicines Company Ready-to-use bivalirudin compositions
GB0915519D0 (en) 2009-09-04 2009-10-07 King S College London Ntithrombotic compounds
WO2011071799A2 (en) 2009-12-11 2011-06-16 Dr. Reddy's Laboratories Ltd. Purification of bivalirudin
US7985733B1 (en) 2010-01-06 2011-07-26 The Medicines Company Buffer-based method for preparing bivalirudin drug product
CN101906150B (zh) 2010-06-28 2013-01-09 上海昂博生物技术有限公司 一种比法卢定的制备方法
US20120041173A1 (en) 2010-08-16 2012-02-16 Cem Corporation Water soluble solid phase peptide synthesis
KR20120069288A (ko) 2010-12-20 2012-06-28 주식회사 씨트리 수용성 당 알코올을 이용한 비바리루딘의 정제방법
CN102260323A (zh) 2011-05-30 2011-11-30 杭州诺泰制药技术有限公司 固相液相结合制备比伐卢定的方法和检测方法
WO2012165546A1 (ja) 2011-05-31 2012-12-06 味の素株式会社 ペプチドの製造方法
CN102286076B (zh) 2011-06-23 2014-03-12 成都圣诺科技发展有限公司 比伐卢定的制备方法
CN102336813B (zh) 2011-07-01 2016-01-06 上海苏豪逸明制药有限公司 一种固相多肽合成蛋白溶菌素的制备方法
US8906681B2 (en) 2011-08-02 2014-12-09 The Scripps Research Institute Reliable stabilization of N-linked polypeptide native states with enhanced aromatic sequons located in polypeptide tight turns
WO2013042129A1 (en) 2011-09-23 2013-03-28 Natco Pharma Limited Improved process for preparation of bivalirudin
CN102532274B (zh) 2012-02-13 2014-04-23 成都圣诺生物制药有限公司 一种比伐卢定的制备方法
CN102641506B (zh) 2012-04-11 2013-10-23 承德医学院中药研究所 比伐卢定-聚乙二醇化复合物
CN102731624B (zh) 2012-06-14 2015-09-23 无锡市凯利药业有限公司 一种固相片段法合成比伐卢定的方法
CN102702325B (zh) 2012-06-19 2015-09-23 深圳翰宇药业股份有限公司 一种抗凝血多肽的制备方法
CN102924575B (zh) 2012-10-31 2014-12-31 深圳翰宇药业股份有限公司 一种比伐卢定的制备方法

Also Published As

Publication number Publication date
DE602005023429D1 (de) 2010-10-21
ES2352204T3 (es) 2011-02-16
US20080287648A1 (en) 2008-11-20
CN101094867A (zh) 2007-12-26
CN102225966A (zh) 2011-10-26
IL182698A0 (en) 2007-09-20
WO2006045503A1 (en) 2006-05-04
USRE46830E1 (en) 2018-05-08
EP1737889B1 (de) 2010-09-08
IL182698A (en) 2013-11-28
DK1737889T3 (da) 2011-01-03
JP2008517018A (ja) 2008-05-22
EP1737889A1 (de) 2007-01-03
CN101094867B (zh) 2011-08-24
CN102225966B (zh) 2012-12-26
PT1737889E (pt) 2010-12-13
US7939629B2 (en) 2011-05-10
JP4903709B2 (ja) 2012-03-28

Similar Documents

Publication Publication Date Title
ATE480561T1 (de) Verfahren zur festphasen-peptidsynthese
DK1987052T3 (da) Syntese af glucagonlignende peptider
ATE425136T1 (de) Verfahren zur herstellung substituierter 3-aryl- butyl-aminverbindungen
TW200508241A (en) Regioselective synthesis of CCI-779
EP1668628A4 (de) Verfahren zum synthetisieren von sprache
DE602004003964D1 (de) Verfahren zur herstellung verzweigter kohlenwasserstoffe
IL186774A0 (en) Method of peptide synthesis
DE60317651D1 (de) Verfahren zur herstellung von hochmolekularen verbindungen für photoresists
ATE408616T1 (de) Verfahren zur aufreinigung von il-18-bindendem protein
ATE398121T1 (de) Neue synthese von irbesartan
ATE346508T1 (de) Süsswaren enthaltend geruchsneutralisierte sojaprotein-zusatzstoffe erhältlich mittels ein spezifisches verfahren
DE602005024305D1 (de) Verfahren zu synthese von glycolonitril
DK1835816T3 (da) Fremgangsmåde til produktion af proteinhydrolysater
DE60327356D1 (de) Verfahren zur synthese von metallnanoteilchen
DE60326604D1 (de) Verfahren zur umwandlung von polysulfanen
ATE404613T1 (de) Verfahren zur herstellung eines pulvers mit hohem gerbstoffgehalt
DE502004005049D1 (de) Verfahren zur herstellung von amino-gruppen tragenden silicium-verbindungen
TW200720288A (en) Method of peptide synthesis
DK1480998T3 (da) Mellemprodukter og fremgangsmåder til fremstilling af heptapeptidoxytocinanaloger
NO20042003L (no) Fremgangsmate for 2-trinns syntese av heksanitroheksaazaisowurtzitan ved a starte fra et primaert amin
MX2007004184A (es) Sintesis de peptido en fase solida.
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
ATE484599T1 (de) Verfahren zur herstellung von leder
ATE399167T1 (de) Verfahren zur halbsynthese von deserpidin
FR2865725B1 (fr) Methode de synthese de solides lamellaires a partir d'un structurant organique de type amino-alcool

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties